Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/20 → 1/1/27

Funding

  • National Cancer Institute